AGP Executive Report
Last update: 10 hours agoHepatitis B Vaccine Trial: The University of Southern Denmark has reportedly approved a controversial Guinea-Bissau study, with the CDC seeking $1.6 million to support it. The trial would withhold the protective birth-dose vaccine from half of 14,000 newborns. Health advocates condemn the plan as unethical; nearly one in five people in Guinea-Bissau has hepatitis B. Regional Disease Watch: ECOWAS health and veterinary officials met in Togo to strengthen surveillance and control of cross-border animal diseases, including avian influenza, rabies and foot-and-mouth disease—threats to livelihoods and food security across West Africa.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.